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Summary Tumour blood flow was characterised in a 'tissue-isolated' rat tumour model, in which the vascular
supply is derived from a single artery and vein. Tumours were perfused in situ and blood flow was calculated
from simultaneous measurement of (1) venous outflow from the tumour and (2) uptake into the tumour of
radiolabelled iodo-antipyrine (IAP). Comparison of results from the two measurements enabled assessment of
the amount of blood 'shunted' through the tumours with minimal exchange between blood and tissue. Kinetics
of IAP uptake were also used to determine the apparent volume of distribution (VDapp) for the tracer and the
equilibrium tissue-blood partition coefficient (A). A was also measured by in vitro techniques and checks were
made for binding and metabolism of IAP using high-pressure liquid chromatography. VDapp and A were used
to calculate the perfused fraction (a) of the tumours. Tumour blood flow, as measured by IAP (TBFIAP), was
94.8 ± 4.4% of the blood flow as measured by venous outflow, indicating only a small amount of non-
exchanging flow. This level of shunting is lower than some previous estimates in which the percentage tumour
entrapment of microspheres was used. The unperfused fraction ranged from 0 to 20% of the tumour volume
in the majority of tumours. This could be due to tumour necrosis and/or acutely ischaemic tumour regions.
For practical purposes, measurement of the total venous outflow of tumours is a reasonable measure of
exchangeable tumour blood flow in this system and allows for on-line measurements. Tracer methods can be
used to obtain additional information on the distribution of blood flow within tumours.
Tumours become vascularised under the influence of tumour-
derived angiogenic factors (Folkman, 1985). After vessel
formation, tumour growth has a large influence on the subse-
quent vascular pattern. Rubin and Casarett (1966) described
two types of tumour vascularisation, a central type with
vessels branching outwards from the tumour centre and a
peripheral type where the largest vessels are apparent at the
tumour periphery and necrosis tends to develop centrally.
Falk (1980) proposed that central vascularisation is the more
basic form from which the peripheral form may develop as a
result of the 'stresses and strains' of tumour growth.
Examples of the effects of such stresses and strains include
the characteristic tortuosity of tumour blood vessels, oc-
clusion of vessels and dilatation of vessels upstream from
occluded sites, all of which are likely to be induced by
pressure from division of surrounding tumour parenchymal
cells (Warren, 1979; Falk, 1980; Shubik, 1982). Capillary
lengthening is another commonly observed feature of
tumours and is probably caused by stretching forces of the
growing tumour as well as incorporation of tumour paren-
chymal cells into the vessel wall (Endrich et al., 1982; Dew-
hirst et al., 1989). Such vessels are thus often devoid of true
endothelial cell linings which could, in turn, lead to platelet
and leucocyte adherence.
In view of these anatomical characteristics, it is not sur-
prising that both spatial and temporal heterogeneity of
tumour blood flow have been reported (Chaplin et al., 1987;
Tozer et al., 1990). Regions of very low blood flow may
result from large intercapillary spaces and/or occluded blood
vessels and these regions would be unfavourable for the
uptake of chemotherapeutic drugs into tumours. It has also
been proposed that conditions in the growing tumour des-
cribed above could give rise to the development of arterio-
venous anastomoses (Tveit et al., 1987; Vaupel et al., 1989)
resulting in a high proportion of 'shunted' blood from which
there is little exchange with the surrounding tumour cells.
Again, this would be a barrier to effective chemotherapy.
We have used a 'tissue-isolated' preparation, in which the
tumour microcirculation is derived from a single artery and
vein, in order to investigate the perfused fraction and level of
shunted blood flow in the P22 rat carcinosarcoma perfused in
situ. Venous outflow from the tumour, which measures total
tumour blood flow, was compared with blood flow measured
by the uptake of radiolabelled iodo-antipyrine (IAP), for
assessment of shunting. External gamma counting of tumour
levels of IAP at long times (up to 2 h) after administration of
IAP allowed the measurement of the tissue-blood partition
coefficient of the tracer (A). The apparent volume of distribu-
tion for IAP (VDapp) was calculated from the kinetics of its
uptake at a short time (400 s) after administration. Com-
parison of and VDapp allowed calculation of a perfused
fraction for the tumour (a). A was also measured separately,
under in vitro conditions, for comparison. High-performance
liquid chromatography (HPLC) measurements of IAP levels
in tumour and blood were made to check for any metabolism
of IAP which could affect the interpretation of the in vivo
data.
Materials and methods
Tumours
A transplanted rat carcinosarcoma, designated P22, was used
for these experiments. Its origin and maintenance in BD9 rats
have been described previously (Tozer & Shaffi, 1993). Early-
generation tumours (third to tenth generation away from the
primary tumour), growing subcutaneously in the flanks of
male BD9 rats, were excised and used as donor material for
the propagation of tissue-isolated tumours in recipient male
BD9 rats. This type of preparation was first described by
Gullino and Grantham (1961a) and in the inguinal site by
Grantham et al. (1973). We have previously used tissue-
isolated tumours for ex vivo perfusions with physiological
buffer, in order to investigate the relationship between flow
and perfusion pressure (Sensky et al., 1993). We now describe
a system for in vivo perfusion with blood. Recipient rats were
anaesthetised by intraperitoneal injection of fentanyl citrate
(0.315mg kg-') and fluanisone (10mg kg-') (Hypnorm,
Crown Chemical and midazolam (5 mg kg-') (Hypnovel,
Roche). A small incision was made in the skin over the right
hind leg and a small section (t0.2 g) of the right inguinal fat
pad was surgically isolated together with the proximal por-
tion of the right superior epigastric artery and vein which
branch from the right femoral artery and vein respec-
tively.
Donor tumour was implanted into the isolated fat as a
slurry prepared by mincing the donor tumour with scissors
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followed by aspiration through hypodermic needles of de-
creasing sizes. Moulded silicon chambers made from Silastic
MDX4-4210 medical grade elastomer (Dow Corning) were
used to enclose the fat and growing tumour in order to
prevent ingrowth of new blood vessels from surrounding fat,
skin or muscle. The chambers were constructed so as not to
constrict the vascular pedicle and to allow drainage of fluid.
Chambers were loosely sutured to subcutaneous fat to pre-
vent them twisting in the inguinal cleft and thus constricting
the vascular pedicle. Wounds were stitched and teeth were
clipped to prevent the animals from interfering with their
stitches. Lost fluid from evaporation was replaced by sub-
cutaneous injection of several millilitres of dextrose/saline
solution and rats were placed on a heated blanket until
partial recovery from the effects of anaesthesia. They were
subsequently housed in separate cages with free access to
both soft and regular diet and water. Three to four days after
the operation rats were reanaesthetised lightly with halothane
and the teeth reclipped.
Surgicalpreparation
Tumour growth was assessed qualitatively by palpation and
tumours grew to fill the chambers within 2 -3 weeks of
implantation. Tumours could grow to a maximum size of
approximately 0.8 g within the chambers. When larger
tumours were required animals were reanaesthetised with
halothane and nitrous oxide in oxygen, a skin incision was
made and part of the chamber was cut away to allow further
tumour growth. Wounds were stitched and teeth were clip-
ped. Growth could proceed in this way for several days
without any ingrowth of new blood vessels.
Animals were prepared for experimentation when tumours
reached 0.5-1.5 g in weight. Animals were reanaesthetised
with Hypnorm and midazolam and the skin overlying the
tumour reopened. The surgical procedure is shown in Figure
1. The saphenous artery was catheterised with a polyethylene
catheter (internal diameter 0.28 mm, Portex) such that the
catheter tip passed along the femoral artery until it was just
distal to the tumour (superior epigastric) artery. The femoral
vein was catheterised using wide-bore silicon tubing with a
narrower polyethylene tip (internal diameter 0.58 mm,
Portex) for insertion into the vein. The catheter was posi-
tioned such that its tip wasjust distal to the tumour (superior
epigastric) vein. A piece of suture thread was placed under
the femoral vein proximal to the tumour vein. All other
vessels near the catheterisation site, including the saphenous
r Tumour
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Figure I Surgical preparation of the vasculature in the right
inguinal cleft of the BD9 rat 'for in situ isolation of the tumour
blood supply. Small blood vessels not shown in the diagram are
occluded by cauterisation. Not to scale.
vein and muscular artery and vein, were ligated or
cauterised.
The catheterisation procedure permitted the administration
of IAP directly to the tumour without its entry into the
systemic circulation and without interference with the blood
supply to the tumour from the femoral artery. It also enabled
collection of venous outflow from the tumour without dis-
rupting its arterial supply. The tumour was kept warm and
moist throughout the surgical procedure. A tail artery and
two tail veins were also catheterised using polyethylene tub-
ing (internal diameter 0.58 mm, Portex) and the wounds
strapped. Mean arterial blood pressure (MABP) was moni-
tored continuously via a physiological pressure transducer
(Gould Instruments Systems) connected to the tail artery
catheter. The preparation was left undisturbed for approx-
imately half an hour before further experimentation. MABP,
for the whole group of animals, was 87.0 ± 0.3 mmHg
immediately after catheterisation and did not vary
significantly throughout the course of the experiment.
Isolation of tumour bloodsupply and measurement of venous
outflow
After the rest period, rats were heparinised by intravenous
bolus injection via the tail vein catheter, (0.1 ml heparin,
1,000 unitsml-', CP Pharmaceuticals). Venous drainage from
the tumour was diverted from the femoral vein to the venous
catheter by tying off the suture around the femoral vein.
Venous blood was collected every 1-2 min into preweighed
vials with the aid of a fraction collector. Continuous
monitoring of venous outflow in ml min-' was obtained by
weighing each blood sample and using a value of 1.05 for the
density of whole blood. Tumour weight, measured at the end
of the experiment, was used to calculate venous outflow in
ml g-' min-'.
Blood volume of the rat was maintained constant by infu-
sion of donor blood*, via a peristaltic pump, into a
catheterised tail vein. The rate of infusion was continually
adjusted to equal the venous outflow measured in the
previous 1-2 min time interval. Despite the delay involved
here, there was never more than a 5% discrepancy between
venous outflow and rate of blood replacement over the time
course of each experiment. This difference had no effect on
systemic blood pressure. The reservoir of donor blood was
stirred continuously. Top-up doses of anaesthetic were
administered intraperitoneally at regular intervals and rats
were kept warm using an angle-poise lamp and a thermo-
statically controlled heating blanket connected to a rectal
thermocouple. Surface tumour temperature was monitored
using a second thermocouple and maintained between 34.0
and 36.5°C throughout the experimental period using the
lamp.
Measurement of tumour bloodflow using IAP (TBFAp)
TBFIAP was measured using the uptake of radiolabelled IAP
into the tumour in one of two ways. In the first method,
tumours were shielded from the rest of the rat by placing
them on a specially constructed lead platform which enabled
a gamma scintillation counter (diameter 1.2cm), with lead
*Blood was obtained from donor animals 1-5 days before the
experiment. Donor animals were anaesthetised with Hypnorm and
midazolam for catheterisation of the right carotid artery. Between 10
and 20ml of free-flowing arterial blood was collected from each
animal under terminal anaesthesia into citrate-phosphate-dextrose
(CPD) solution [0.14 ml ofCPD (Sigma Chemical Co., Poole, Dorset,
UK) to I ml of whole blood]. Blood samples were refrigerated until
required and then recalcified using 0.02 ml ofcalcium gluconate (10%
solution) per ml of whole blood and heparinised using 0.005 ml of
heparin (1,000 unitsml-') per ml ofwhole blood. Blood samples were
then spun down and part of the supernatant removed in order to
adjust the haematocrit to that of the recipient rat. Red cells were
resuspended and the samples warmed to 37°C in a water bath ready
for infusion into the recipient rat.
I1042 G.M. TOZER et al.
collimating sleeve, to be placed over the tumour without
stretching or constriction of the tumour vascular pedicle.
'25I-labelled IAP ('251-IAP, Amersham), at a concentration of
0.074-0.37 MBq (2- 10pCi) per ml of saline, was given as a
constant infusion to the tumour via the arterial catheter at
approximately 5% (never more than 7%) of the rate of the
total venous outflow. Tumour levels of IAP were measured
continuously via the gamma counter and recorded on a
Macintosh Ilci computer using electronic interfaces
constructed 'in-house'. Venous levels of IAP (c.p.m. g1')
draining the tumour were measured from timed venous
samples counted in a well-type scintillation counter (LKB).
At the end of the experiment (1-2 h after the start of IAP
infusion) rats were killed using bolus intravenous injection of
Euthatal (RMB Animal Health) and the tumour rapidly
excised, weighed and counted in the well counter. These
counts were used to determine a factor which was used to
convert all the data from the external counter into equivalent
well counter counts. Venous outflow (ml min-') was
monitored continuously throughout the experiment.
In the second method for measuring TBFIAP, IAP was
infused systemically over a short time period and tumour
levels of IAP were measured after excision, by scintillation
counting. This method has been published previously for
subcutaneous P22 tumours (Tozer & Shaffi, 1993). Briefly,
the tail artery catheter was disconnected from the pressure
transducer and connected to a fraction collector loaded with
preweighed vials and 0.37 MBq (10,Ci) of '251I-IAP or '4C-
labelled IAP ('4C-IAP) in 0.8 ml of saline was infused into
the second catheterised tail vein over a period of 30 s. During
the 30 s period free-flowing arterial blood from the tail artery
catheter was collected into preweighed vials at 1 s intervals.
At the end of 30 s the tumour vascular pedicle was ligated
close to the tumour and the tumour excised. Venous outflow
from the tumour was monitored continuously throughout the
experiment. The tumour and blood samples were weighed
and counted using the well counter for samples containing
1251 and liquid scintillation for samples containing '4C as
described by Tozer and Shaffi (1993). Measurement of
venous outflow from the tumour was continued for approxi-
mately 10 min after excision of the tumour in order to deter-
mine the level of residual flow in the vascular pedicle. The rat
was then killed using a bolus intravenous injection of
Euthatal.
Calculation of TBF,Ap
Calculations of TBFIAP from data obtained using the two
methods described above were based on the Kety (1960)
model:
Cti.(t) = k, Ca(t) ®De-k2t (1)
where CQ,,(t) is concentration of label in the tumour as a
function of time, t, in c.p.m. g-', k, is TBFIAP per g of whole
tumour in ml g-' min-', Ca(t) is the concentration of label in
the arterial blood entering the tumour as a function of t, in
c.p.m. ml-', denotes the convolution integral, and k2 = kl
al where x is the fraction of tumour effectively perfused and
A is the equilibrium partition coefficient of the tracer between
tissue and blood (oaA is equivalent to VDapp, the apparent
volume of distribution of the label in the tissue relative to the
blood).
In the first method Cti,s(t) was measured continuously over
the experimental period, and the concentration of label in
blood at the arterial infusion site [Cj(t), c.p.m. ml-'] was
calculated from the infusion rate of IAP into the artery, the
concentration of IAP in the infusate and the rate of venous
outflow of blood from the tumour, also measured throughout
the experiment. The relationship between Cj(t) and Ca(t)
involves a short delay before the tracer reaches the tumour
and a dispersion or smearing of the tracer as it mixes with
the arterial blood. Such effects are important at early times in
blood flow measurements (Lammertsma et al., 1990). Delay
was estimated by comparing the time of start of infusion with
the initial rise in tumour activity and the time scales of the
blood and tissue measurements were adjusted accordingly.
An exponential model of dispersion in blood sampling has
been described by lida et al. (1986). In the present model we
have applied such a correction to the delivery of tracer to the
tumour, such that:
Ca(t) = Cj(t)®$ kde kdl (2)
where kd is a dispersion constant.
Combination of equations (1) and (2) gives the final model
equation for the first method as:
C,i. (t) = (klkd)!(kd- k2) Ci(t) C (e k21- ekdt} (3)
Least mean squares estimates of kl, k2 and kd were obtained
from a non-linear regression of Cti,s(t) on C1(t) using equation
(3) on data measured over the first 400 s of infusion of IAP
as described above. The residual sum of squares was mini-
mised using a simplex algorithm (Nelder & Mead, 1965).
VDapp was calculated from the estimates of k, and k2 (see
above). A. was measured, where possible, from the ratio of
tissue to blood levels of IAP at the end of the experiment
(1-2 h after start of infusion). The perfused fraction, a, is
equivalent to the ratio VDapp/A.
In the second method, calculation of TBFIAP was again
based on equation (1). Here the concentration of IAP was
measured in excised tumours following a short intravenous
systemic infusion of the tracer (30 s), and the arterial concen-
tration of tracer was measured from continuous tail artery
sampling [Cm(t)].' Here the delay and dispersion effects occur
in the arterial sampling catheter, such that:
Cm(t) = Ca(t) 0 kd e -kd' (4)
In this method, Ctis,(t) is measured at only one time point,
i.e. in the tumour after excision. Hence only one parameter,
k, =TBFIAP, can be estimated from the data. VDapp was
assumed to be 0.74 (see Results section). Over such a short
time period the method is relatively insensitive to small
changes in VDapp (Lammertsma et al., 1992). Values for delay
and dispersion in the plastic catheters were obtained from
measurements made in vitro (G.M. Tozer & V.J. Cunning-
ham, unpublished data). Cm(t) was then deconvolved to give
Ca(t) (equation 4). The expected value of Cjss(t) at 30 s was
then calculated over a range of blood flow rates, using
equation (1), to give a look-up table for each individual
tumour, from which the corresponding TBFIAP was obtained
(Tozer & Shaffi, 1993).
In vitro measurement oftissue-bloodpartition coefficient (A)
for '251I-IAP
Plasma samples were obtained by centrifugation of whole
blood collected, by carotid artery catheterisation, from
heparinised BD9 rats under terminal anaesthesia. Approx-
imately 0.111 MBq (3 pCi) of 251I-IAP was added to each ml
of plasma.
Five tissue-isolated, freshly excised tumours were used.
Each tumour was cut into two pieces symmetrically about
the vascular pedicle. The two pieces were weighed and
incubated in '251-labelled plasma for 2-3 h at 37°C to allow
diffusion of IAP into the tissue samples. At the end of the
equilibration period one tumour piece from each tumour as
well as the appropriate plasma sample was counted using the
well counter. The second piece from each tumour was frozen
in isopentane at -40 to -50°C for cryostat sectioning.
Sections 20tim thick were obtained from the centre of each
tumour piece and used to produce autoradiograms of IAP
distribution on X-ray film as described by Tozer and Shaffi
(1993).
Autoradiograms were used solely to check for uniformity
of IAP distribution throughout the tumour pieces. This was
apparent for all five tumours. A for 251I-IAP was calculated
from tissue counts per g divided by plasma counts per g
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Determination ofIAP metabolism
A rat bearing a tissue-isolated tumour was catheterised as
described above for isolation of tumour blood supply.
Venous outflow was collected during continuous infusion of
'25I-IAP into the tumour artery as described above. At inter-
vals throughout the infusion, 100pl whole blood from the
venous outflow was frozen in isopentane at -40 to - 50°C.
At the end of the experiment the excised tumour was also
frozen. Sample were stored at - 70°C before further
analysis.
A 1 ml aliquot of methanol was added to each of the
thawed blood samples, which were mixed throroughly and
centrifuged. Supernatants were removed and pellets were re-
extracted. The supernatants were pooled, dried under nitro-
gen and redissolved in 200 il of water. Tumour samples were
weighed and homogenised in four volumes of water. A 3 ml
aliquot of methanol was added to a 500 "l aliquot of
tumour/water mixture and extracted as described for the
blood samples.
A gradient separation of the blood and tumour samples
was carried out by high-performance liquid chromatography
(HPLC) using a Hichrom RPB column and water (A) and
75% acetonitrile (B) as the two eluents. The linear gradient
ran from 30 to 70% B in 5 min and the flow rate was
1.5 ml min-'. Todo-antipyrine eluted at 5-6 min. Fractions of
the eluate were collected at I min intervals and counted in
the well counter.
Statistics
Errors associated with mean values are one standard error of
the mean. Straight lines were fitted by regression analysis
with correlation coefficients (R) shown on the graphs. F-tests
were used to determine whether linear fits were statistically
better fits for the data than the overall mean. P-values of less
than 0.05 were considered to be significant. Standard errors
of combinations of parameters were calculated using the
rules summarised by Wilkinson (1961).
Results
Figure 2 shows two examples (tumour A and tumour B) of
the time course for '251I-IAP uptake into tumour tissue during
a constant infusion of tracer into the arterial blood directly
supplying the tumour. The corresponding activities in venous
blood draining the two tumours are also shown. The similar
shapes of the venous and tissue curves are consistent with the
Kety model (see above), which assumes rapid equilibration of
tracer between blood and tissue. The data show a rapid
initial uptake phase followed by a plateau phase, which is
consistent with the expected behaviour of a readily diffusible
tracer. The equilibrium partition coefficient of IAP between
tissue and blood (A) was calculated from equilibrium levels of
IAP during the plateau phase (equal to tumour counts +
venous blood counts) and was found to be very similar for
the two tumours (Figure 2).
TBFIAp and VDapp, for each tumour, were determined from
the first 400 s of the calculated arterial blood levels and the
measured tumour levels of IAP (see Materials and methods).
The first 400 s of the tumour data shown in Figure 2 are
replotted in Figure 3 together with the calculated arterial
blood levels at the infusion point. These data represent C11j,(t)
and CQ(t) respectively. Corresponding best fits to the tumour
data are shown by the solid lines. Comparison of these data
for the two tumours (A and B) shows that, despite similar
values for A, the initial uptake kinetics for the two tumours
were rather different. Tumour levels of IAP for tumour A
plateaued quickly and were tending to a relatively high frac-
tion of the arterial blood IAP levels. This is reflected by
relatively high values for TBFIAp and VDapp respectively,
compared with those for tumour B, as shown in Figure 3.
VDapp for tumour A is very similar to its A, leading to a
perfused fraction, a, equal to 1.05 (a = VDapp/A). A lower
VDapp for tumour B leads to a lower perfused fraction for
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Figure 2 Two examples (tumour A and tumour B) of the uptake
of '251-IAP into the P22 tumour growing as a tissue-isolated
preparation. Open symbols (0) represent tumour levels of 1251-
IAP and closed symbols (U) represent venous blood levels. 1 was
calculated to be 0.708 ± 0.002 for tumour A and 0.712 ± 0.005
for tumour B.
this tumour (a = 0.81). Identical calculations were made for
the other 11 tumours in this group.
A, for 9 out of 13 animals, was 0.74 ± 0.04, which is not
significantly different from the value of 0.71 ± 0.01 (n = 5)
calculated from in vitro exposure of tumour tissue and blood
to '25I-IAP (see Materials and methods). In four animals,
distribution of '25I-IAP did not reach equilibrium within the
time course of the experiment. In these cases, a value of 0.74
was assumed for A. HPLC results showed that, after constant
infusion of '25I-IAP for approximately an hour and a half,
89% of 1251 tumour counts resided in the peak associated
with IAP, 11% were associated with the alcohol-insoluble
tissue fraction and <1% appeared in a lower molecular
weight peak. These results indicate a small amount of bind-
ing and metabolism of the tracer in the tumour tissue. How-
ever, almost identical values were obtained for whole venous
blood samples, such that A calculated from total 125I in
tumour and blood was within 5% of the value calculated
from 1251 in the IAP fraction. The value of 0.74, calculated
from total '25I counts in tumour and blood in vivo, was
therefore considered to be a true measure of the tissue-blood
partition coefficient for '25I-IAP in this tumour system. This
compares with a value of 0.8 previously reported for '4C-IAP
in the brain (Sakurada et al., 1978) and in subcutaneous rat
tumours (Tozer & Morris, 1990).
Figure 4 shows the relationship between VDapp and per-
fused fraction (a) and the initial venous outflow for the
whole group of 13 tumours. VDapp tends to increase with
increasing blood flow (R = 0.70, P = 0.008), suggesting that
low blood flow is associated with poor access of '25I-IAP to
all tumour regions (Figure 4a). However, despite a tendency
for oa to be lower at lower tumour blood flow, there was too
much scatter in the data for this to be significant (Figure 4b).
Figure 4b shows that ax was within approximately 80% of the1044 G.M. TOZER et al.
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whole tumour volume for 10 out of 13 tumours. An unper-
fused fraction of 0-20% is consistent with tumour necrosis
or possibly acutely ischaemic tumour regions (Chaplin et al.,
1987). An unperfused fraction of less than 50% was observed
in a minority of cases (3 out of 13 tumours).
In a second group of 15 tumours, venous outflow was
measured after removal of the tumour at the end of TBFIAP
determination (measured over 30 s, see Materials and
methods). Although there was a tendency for venous outflow
to decrease with increase in tumour size, this was not
significant for the number of tumours and the size range used
(results not shown). Figure 5 shows that there was a
significant residual venous outflow after the tumour had been
removed. This flow must be either arteriovenous anastomoses
or nutritive blood flow within the vascular pedicle which
usually develops a fatty sheath during tumour growth. Mean
residual flow for 13 animals shown in Figure 5 was 12.5 +
1.5% of the total venous outflow measured immediately
before removal of the tumour. Residual flow was not
measureable in 2 out of 15 animals, and a value of 12.5%
was used for these animals (not shown in Figure 5). The
tendency for the percentage residual blood flow to decrease
with increase in tumour size could be explained by a constant
flow to the pedicle concomitant with an increasing total
blood flow as tumour burden increases. However, this does
not reach statistical significance with the numbers of animals
used (P = 0.098).
Figure 6 shows the relationship between venous outflow,
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Time after start IAP infusion (s)
Figure 3 The early time courses of '251-IAP uptake into the two
tumours shown in Figure 2 (0) together with their respective
arterial levels (x). These data represent C,,,(t) and C,(t) respec-
tively in the calculation of TBFIAp. The solid line represents the
best fit through the tumour data. TBFIAP was calculated to be
0.435 ± 0.012 ml g-' min-' for tumour A and 0.244 ± 0.009 ml
g-' min-' for tumour B. VDapp was 0.743 ± 0.005 for tumour A
and 0.578 ± 0.009 for tumour B.
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Figure 5 The relationship between residual blood flow in the
vascular pedicle supplying the tumour and tumour weight. Each
point represents a single tumour. The solid line is the best
straight-line fit through the data.
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Figure 4 The relationship between VDappand venous outflow (a)
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tissue-isolated preparations of the P22 tumour. Each point
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fit through the data.
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Figure 6 The relationship between tumour blood flow as
measured by uptake of IAP (TBFIAp) and tumour blood flow as
measured by venous outflow from tissue-isolated tumours. Each
point represents a single tumour. The solid line is the best
straight-line fit through the data. The dashed line is the line of
equivalence.
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corrected for residual flow in the vascular pedicle, versus
TBFIAP. A linear relationship (R = 0.84) is significant
(P = 0.0004). On average, TBFIAP was 94.8 ± 4.4% of the
venous outflow. Venous outflow measurements will include
the nutritive blood flow to the tumour as well as blood which
is 'shunted' from the arterial to the venous side of the
circulation with minimal exchange of solutes between blood
and tumour tissue. TBFIAP will include very little of the
shunted flow since the method relies on uptake of the radio-
tracer into the tissue. The small discrepancy between the two
measurements therefore suggests that only a small percentage
(approximately 5%) of blood passing through the tumour
was shunted blood.
Discussion
The tissue-isolated tumour preparation combined with radio-
tracer techniques provided a means for quantifying some of
the characteristics of tumour blood flow. In particular, we
were able to determine the total venous outflow from the
tumour, the perfused fraction of the tumour and the amount
of shunted blood which passes through the tumour without
any significant nutrient exchange. Total venous outflow
included a significant amount of blood flow to the vascular
pedicle (approximately 10-20%) which can be minimised by
using tumours as large as possible.
The perfused fraction of the tumour (a) was obtained from
a comparison of VDapp (estimated from data collected over a
400 s continuous infusion of IAP) and the corresponding
equilibrium partition coefficient (A). a was generally
80-100% of the tumour volume. This can be explained by
necrosis and/or the presence of acutely ischaemic tumour
regions, where low or non-existent perfusion would preclude
local delivery of IAP to the tumour tissue. Our data were
insufficient to determine whether increased venous outflow
affected the perfused fraction. However, a separate study has
shown that increasing the venous outflow above normal, by
increasing the blood volume and therefore the perfusion
pressure, has no effect on tumour vascular resistance,
suggesting that this is not the case (unpublished data). It
should also be noted that, in general, heterogeneity of local
blood flow rates may lead to a low VDapp, as estimated using
the single-compartment Kety model (lida et al., 1989). Heter-
ogeneous blood flow is a characteristic feature of tumours
and has been demonstrated in the P22 tumour using quanti-
tative autoradiography (Tozer & Shaffi, 1993).
The shunted fraction was rather variable between individ-
ual tumours but, on average, only accounted for about 5%
of the total venous outflow. This value is smaller than sug-
gested in some previous publications which have relied on
measurement of the fraction of arterially administered micro-
spheres (average diameter approximately 15jim) which
escape trapping in the tumour microcirculation (Wheeler et
al., 1986; Tveit et al., 1987). This method assumes that large
tumour vessels play no part in nutrient exchange and thus
may overestimate the true shunted fraction of blood. Wheeler
et al. (1986), in their study of human head and neck cancer,
also suggested that some of the shunting they observed (on
average 23% of the total blood flow) may have been in
normal tissue rather than in the tumour itself. Goldberg et al.
(1991) have discussed the problems associated with using
microspheres for measurement of shunted fraction and con-
cluded that once errors such as leaching of radioactivity from
the spheres and heterogeneity in sphere size were minimised
the shunted fraction within human liver metastases could be
reduced to less than 6%. Gullino and Grantham (1961b),
who developed the original method for growing 'tissue-
isolated' tumours in the ovarian site, used uptake of 42KC1 or
86RbCl and Sapirstein's principles (Sapirstein, 1958) to deter-
mine blood flow to rat tumours growing in the ovary for
comparison with the total venous outlfow. Their calculations
included assumptions for the cardiac output of the host rats
and they did not compare their tracer uptake method for
blood flow with venous outflow in the same animals. How-
ever, in separate groups of animals, the mean blood flow
values for the two methods were very similar, suggesting that
there was minimal shunting of blood in these tumours. It is
possible that tissue-isolated tumours contain less shunted
blood than other tumours but this is a very difficult issue to
address experimentally. For the P22 tumour, spatial hetero-
geneity of TBFIAP in tissue-isolated preparations is very
similar to that in subcutaneous ones (unpublished data),
suggesting that the vessel arrangement is similar for the two
types. However, we cannot rule out the possibility that the
tissue-isolated preparation per se is a major determinant of
the degree of shunting present. Similarly, the influence of
anaesthesia on the shunted fraction is unknown.
Taken together, evidence to data suggests that the amount
of blood shunted through tumours, with minimal nutrient
exchange, is less than previously supposed (Vaupel et al.,
1989). Since the amount of shunted blood in tumours has
considerable implications for chemotherapy and the oxygena-
tion of tumours, more studies are required to determine the
degree of shunting in different tumour types.
For practical purposes, we have shown that measurement
of total venous outflow is a good measurement of exchange-
able tumour blood flow in our system, as long as a correction
is made for the blood supply to the vascular pedicle. This
method allows for on-line measurement of absolute blood
flow in these tissue-isolated preparations. Tracer methods
allow for only a single blood flow measurement but have the
advantage that they can be adapted to provide microregional
information by using quantitative autoradiography for
assessment of tissue tracer levels (Tozer & Shaffi, 1993). Our
blood flow calculations from tracer uptake kinetics include a
correction for blood delayed and dispersed in the plastic
cannulae used for collection of arterial blood. Failure to take
these effects into account can cause significant errors (lida et
al., 1986). The present study has shown that tumours com-
monly contain regions which are not readily accessible to
diffusible tracers, resulting in a low apparent volume of
distribution for the tracer at early times after injection. The
true volume of distribution (or tissue-blood partition
coefficient, A) can only be obtained by equilibrium studies.
An accurate measurement of volume of distribution is
required for the application of these methods to tumour
blood flow measurement.
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